Analyst Upgrades – Genocea Biosciences (NASDAQ:GNCA) Stock Gets Upgraded By Needham & Company LLC from Hold to Buy

ME Staff
-
0

Analyst Ratings For Genocea Biosciences (NASDAQ:GNCA)

Today, Genocea Biosciences (NASDAQ:GNCA) stock received an upgrade by Needham & Company LLC from Hold to Buy with a price target of $3.00.

Some recent analyst ratings include

  • 2/6/2018-Needham & Company LLC Upgrade from a “Hold ” rating to a ” Buy” rating.
  • 11/2/2017-Piper Jaffray Companies Reiterated Rating of Overweight.
  • 9/26/2017-Cowen Reiterated Rating of Buy.
  • 9/25/2017-Stifel Nicolaus was Downgraded by analysts at Stifel Nicolaus from a “Buy ” rating to a ” Hold” rating. They now have a $2.50 price target on the stock, up previously from $15.00 .
  • 1/23/2017-FBR & Co Reiterated Rating of Outperform.

Recent Insider Trading Activity For Genocea Biosciences (NASDAQ:GNCA)
Genocea Biosciences (NASDAQ:GNCA) has insider ownership of 6.70% and institutional ownership of 12.02%.

  • On 1/17/2018 William D Clark, CEO, bought 25,000 with an average share price of $0.80 per share and the total transaction amounting to $20,000.00.
  • On 7/24/2017 Jonathan Poole, CFO, sold 45,000 with an average share price of $6.00 per share and the total transaction amounting to $270,000.00.
  • On 11/8/2016 Eric S. Hoffman, Insider, bought 7,000 with an average share price of $3.49 per share and the total transaction amounting to $24,430.00.
  • On 11/7/2016 Jonathan Poole, CFO, bought 7,000 with an average share price of $3.34 per share and the total transaction amounting to $23,380.00.
  • On 11/7/2016 William D. Clark, Insider, bought 2,800 with an average share price of $3.49 per share and the total transaction amounting to $9,772.00.
  • On 5/9/2016 Jonathan Poole, CFO, bought 4,000 with an average share price of $3.88 per share and the total transaction amounting to $15,520.00.
  • On 12/16/2015 William D Clark, CEO, bought 3,800 with an average share price of $6.45 per share and the total transaction amounting to $24,510.00.

Recent Trading Activity for Genocea Biosciences (NASDAQ:GNCA)
Shares of Genocea Biosciences closed the previous trading session at 0.93 up +0.02 1.78% with shares trading hands.